Cardlytics, Inc. - Common Stock (CDLX)
Technology › Services-Computer Programming, Data Processing, Etc.
Price History
Feb 9, 2026 — Mar 26, 2026Investment Snapshot
- P/B of 0.68 — trading below book value
- Piotroski F-Score 4/9 — moderate financial health
- Loss-making — negative ROE of -35.3%
- Revenue declining 16% annually
Cardlytics, Inc. - Common Stock (CDLX) is a Technology company operating in Services-Computer Programming, Data Processing, Etc., listed on the NASDAQ , with a market capitalisation of $58 million . Key value metrics: P/B ratio 0.68, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Cardlytics, Inc. - Common Stock — Fundamental Analysis Summary
On financial health, CDLX shows a moderate Piotroski F-Score of 4/9, and negative return on equity of -35.3% (sector average: -3.1%), and elevated leverage with a debt-to-equity ratio of 1.11.
StockPik's composite Value Score for CDLX is 56/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
CDLX shows revenue declining at 16% year-over-year, with earnings growing at 45%.